about
A look at autoimmunity and inflammation in the eyeBirdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatmentInvolvement of B cells in non-infectious uveitisDual, HLA-B27 Subtype-dependent Conformation of a Self-peptideHLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.Immunotherapeutic strategies in autoimmune uveitisA humanized model of experimental autoimmune uveitis in HLA class II transgenic miceGenetic control of susceptibility in clinical and experimental uveitis.Cytokines in immunotherapy of experimental uveitis.Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy.Experimental autoimmune uveitis and other animal models of uveitis: An update.The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes.Genetics of birdshot chorioretinopathy.Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.Rodent models of experimental autoimmune uveitis.Birdshot uveitis: current and emerging treatment optionsGenetics in ocular inflammation--basic principles.Diagnostic testing and disease monitoring in birdshot chorioretinopathy.HLA-A29 and birdshot chorioretinopathy.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Variation and linkage disequilibrium between a structurally polymorphic Alu located near the OR12D2 gene of the extended major histocompatibility complex class I region and HLA-A alleles.Recovery of visual function in a patient with birdshot chorioretinitis.A bird in the hand.HLA-A29-positive Birdshot Chorioretinopathy in a Hispanic Patient.
P2860
Q24623065-857BDEF7-CB6B-4B41-B4B1-ADD28DC5A41EQ26749730-53FC9311-BAA2-4FC7-8640-7C3E19FFC90CQ26766611-0D2C8A62-DC92-4292-BEA8-336BE3215742Q27642989-86A5E98E-54A4-4108-BCF4-B79B08AF90DAQ33755226-7C175F08-0F3E-4A6F-A282-14040ADE2AAEQ34274950-7E66A935-92A5-402F-9291-05C3BDF0F9A1Q34912369-050F157C-E756-4B24-9107-D93EB6730815Q34993192-41D1CD6D-AD47-4A8D-BEF0-FA777B89CDE0Q34993224-48B5C2C2-9DAA-42F5-B6D7-09EFD2904A4CQ35593241-370F42A8-2D56-46EF-8FB6-6FFDA250F29CQ35663102-B036307A-BA9A-45AD-8107-E49AA5A69001Q36035008-43123805-4362-426D-9DCC-CAA614CC9965Q37063544-C4FC087D-31D0-4425-96B8-76D8B53D2D67Q37094449-DCB65BC0-3FA7-47C4-AD2B-1C61C9C1F5A2Q37262505-0CDD1CDA-4C48-4A68-A0FF-2CA028D09C12Q37412317-A5DF738F-E3E8-43F1-9FFF-96DA0CD2627FQ37830716-D3F3C4E8-4DF4-4CCC-AD40-C5DCC1336B0FQ37940602-2DDA97D8-0D73-4A24-A8D5-83E029A066B5Q37959539-08DEFABD-CD84-409B-B897-7214D4D389D1Q38227621-E62CE572-EB30-45C2-B6FC-4AD57ED49B5DQ42631627-DCB69697-2F56-4B3A-BEDB-27E1E6D60976Q42715866-4977860A-5B10-40B7-917C-04FEBF395E88Q43009078-7DEE0AE6-18D0-4208-844F-025162A672DFQ51128843-F07DA309-A98A-4945-9BC2-71A288032D2A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Spontaneous retinopathy in HLA-A29 transgenic mice.
@ast
Spontaneous retinopathy in HLA-A29 transgenic mice.
@en
Spontaneous retinopathy in HLA-A29 transgenic mice.
@nl
type
label
Spontaneous retinopathy in HLA-A29 transgenic mice.
@ast
Spontaneous retinopathy in HLA-A29 transgenic mice.
@en
Spontaneous retinopathy in HLA-A29 transgenic mice.
@nl
prefLabel
Spontaneous retinopathy in HLA-A29 transgenic mice.
@ast
Spontaneous retinopathy in HLA-A29 transgenic mice.
@en
Spontaneous retinopathy in HLA-A29 transgenic mice.
@nl
P2093
P2860
P356
P1476
Spontaneous retinopathy in HLA-A29 transgenic mice.
@en
P2093
Vieville JC
de Kozak Y
P2860
P304
P356
10.1073/PNAS.051595998
P407
P50
P577
2001-02-13T00:00:00Z